<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified_2" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7843230" created="20/05/2006" creator="Hitomi Masuda"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7843230</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Biphasic control of <term id="T1" lex="nuclear_factor-kappa_B_activation" sem="Other"><term id="T2" lex="nuclear_factor-kappa_B" sem="Protein_molecule">nuclear factor-kappa B</term> activation</term> by the <term id="T3" lex="T_cell_receptor_complex" sem="Protein_complex">T cell receptor complex</term>: role of <term id="T4" lex="tumor_necrosis_factor_alpha" sem="Protein_molecule">tumor necrosis factor alpha</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<clue>Biphasic control of nuclear factor-kappa B <clueType>activation</clueType> by the T cell receptor complex: role of tumor necrosis factor alpha.</clue>
</event>
<event id="E2">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T3"/>
<clue>Biphasic <clueType>control</clueType> <linkTheme>of</linkTheme> nuclear factor-kappa B activation <linkCause>by</linkCause> the T cell receptor complex: role of tumor necrosis factor alpha.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The regulation of <term id="T5" lex="nuclear_factor_(NF)-kappa_B_activation" sem="Other"><term id="T6" lex="nuclear_factor_(NF)-kappa_B" sem="Protein_molecule">nuclear factor (<term id="A100" sem="Protein_molecule">NF</term>)-<term id="A101" sem="Protein_molecule">kappa B</term></term> activation</term> by the <term id="T7" lex="T_cell_receptor_(TcR)/CD3_complex" sem="Protein_complex"><term id="T8" lex="T_cell_receptor" sem="Protein_complex">T cell receptor</term> (<term id="A1" sem="Protein_complex">TcR</term>)/<term id="A2" sem="Protein_molecule">CD3</term> complex</term> in primary human <term id="T9" lex="T_cell" sem="Cell_natural">T cells</term> has been studied at various times after activation.</sentence>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="A100" idref1="A101"/>
<clue>The regulation of nuclear factor (NF)-kappa B <clueType>activation</clueType> by the T cell receptor (TcR)/CD3 complex in primary human T cells has been studied at various times after activation.</clue>
</event>
<event KT="Other" id="E4">
<type class="Binding"/>
<theme idref="A1"/>
<theme idref="A2"/>
<clue>The regulation of nuclear factor (NF)-kappa B activation by the T cell receptor (TcR)/CD3 <clueType>complex</clueType> in primary human T cells has been studied at various times after activation.</clue>
</event>
<event KT="Investigation" id="E5">
<type class="Regulation"/>
<theme idref="E3"/>
<cause idref="E4"/>
<clue>The <clueType>regulation</clueType> <linkTheme>of</linkTheme> nuclear factor (NF)-kappa B activation <linkCause>by</linkCause> the T cell receptor (TcR)/CD3 complex <clueLoc>in primary human T cells</clueLoc> has been <clueKT>studied</clueKT> at various times after activation.</clue>
</event>
<sentence id="S3">Only <term id="T10" lex="p50_NF-kappa_B_protein" sem="Protein_molecule">p50 NF-kappa B protein</term> bound the <term id="A3" sem="DNA_domain_or_region"><term id="T11" lex="kappa_B_element" sem="DNA_domain_or_region">kappa B element</term> of</term> <term id="T12" lex="interleukin-2_receptor_(IL-2R)_alpha_chain_promoter" sem="DNA_domain_or_region"><term id="T13" lex="interleukin-2_receptor" sem="Protein_molecule">interleukin-2 receptor</term> (<term id="T14" lex="IL-2R" sem="Protein_molecule"><term id="A102" sem="DNA_domain_or_region">IL-2R</term></term>) <term id="A103" sem="DNA_domain_or_region">alpha chain promoter</term></term> on resting <term id="T15" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event id="E6">
<type class="Binding"/>
<theme idref="T10"/>
<theme idref="A3" idref1="A102" idref2="A103"/>
<clue>Only p50 NF-kappa B protein <clueType>bound</clueType> the kappa B element of interleukin-2 receptor (IL-2R) alpha chain promoter <clueLoc>on resting T cells</clueLoc>.</clue>
<comment>TPS: A3</comment></event>
<sentence id="S4">However, immediately after <term id="T16" lex="TcR/CD3" sem="Protein_complex"><term id="A4" sem="Protein_complex">TcR</term>/<term id="A5" sem="Protein_molecule">CD3</term></term> cross-linking (after approximately 1 h; immediate) binding of <term id="T17" lex="p50.p65_heterodimer" sem="Protein_complex"><term id="A6" sem="Protein_molecule">p50</term>.<term id="A7" sem="Protein_molecule">p65</term> heterodimers</term> was observed.</sentence>
<event id="E7">
<type class="Binding"/>
<theme idref="A4"/>
<theme idref="A5"/>
<clue>However, immediately after TcR/CD3 <clueType>cross-linking</clueType> (after approximately 1 h; immediate) binding of p50.p65 heterodimers was observed.</clue>
</event>
<event id="E8">
<type class="Binding"/>
<theme idref="A6"/>
<theme idref="A7"/>
<clue>However, immediately after TcR/CD3 cross-linking (after approximately 1 h; immediate) binding of p50.p65 <clueType>heterodimers</clueType> was <clueKT>observed</clueKT>.</clue>
</event>
<event id="E9">
<type class="Binding"/>
<theme idref="T17"/>
<theme idref="A3" idref1="A102" idref2="A103"/>
<clue>However, immediately after TcR/CD3 cross-linking (<clueTime>after approximately 1 h; immediate</clueTime>) <clueType>binding</clueType> <linkTheme>of</linkTheme> p50.p65 heterodimers was observed.</clue>
<comment>No corefTheme</comment></event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="E7"/>
<clue>However, immediately <linkCause>after</linkCause> TcR/CD3 cross-linking (after approximately 1 h; immediate) binding of p50.p65 heterodimers was observed.</clue>
<comment>No clueType</comment></event>
<sentence id="S5"><term id="T18" lex="p50.c-rel_heterodimer" sem="Protein_complex"><term id="A8" sem="Protein_molecule">p50</term>.<term id="A9" sem="Protein_molecule">c-rel</term> heterodimers</term> were also detected bound to this sequence at early time points (7-16 h; early), and both remained active at later time points (40 h; late) after activation.</sentence>
<event id="E11">
<type class="Binding"/>
<theme idref="A8"/>
<theme idref="A9"/>
<clue>p50.c-rel <clueType>heterodimers</clueType> were also detected bound to this sequence at early time points (7-16 h; early), and both remained active at later time points (40 h; late) after activation.</clue>
</event>
<event id="E12">
<type class="Binding"/>
<theme idref="T18"/>
<theme idref="A3" idref1="A102" idref2="A103"/>
<clue>p50.c-rel heterodimers were also detected <clueType>bound</clueType> <linkTheme>to</linkTheme> <corefTheme>this sequence</corefTheme> <clueTime>at early time points (7-16 h; early)</clueTime>, and both remained active at later time points (40 h; late) after activation.</clue>
</event>
<sentence id="S6">This regulation takes place mainly at the level of <term id="T19" lex="nuclear_translocation" sem="Other">nuclear translocation</term> of <term id="T20" lex="p65" sem="Protein_molecule">p65</term> and <term id="T21" lex="c-rel" sem="Protein_molecule">c-rel</term>, at immediate and early time points.</sentence>
<event id="E13">
<type class="Localization"/>
<theme idref="T20"/>
<clue>This regulation takes place mainly at the level of <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> p65 and c-rel, <clueTime>at immediate and early time points</clueTime>.</clue>
</event>
<event id="E14">
<type class="Localization"/>
<theme idref="T21"/>
<clue>This regulation takes place mainly at the level of <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> p65 and c-rel, <clueTime>at immediate and early time points</clueTime>.</clue>
</event>
<sentence id="S7">Activation also induced <term id="A10" sem="RNA_molecule">c-rel</term> and <term id="A11" sem="RNA_molecule">p105</term>/<term id="A13" sem="RNA_molecule">p50 <term id="A12" sem="RNA_molecule">mRNA</term></term> synthesis, but not <term id="T23" lex="p65_mRNA" sem="RNA_molecule"><term id="T24" lex="p65" sem="Protein_molecule">p65</term> mRNA</term> whose expression was constitutive.</sentence>
<event id="E15">
<type class="Transcription"/>
<theme idref="A10" idref1="A12"/>
<clue>Activation also induced c-rel and p105/p50 mRNA <clueType>synthesis</clueType>, but not p65 mRNA whose expression was constitutive.</clue>
<comment>NER T22 del</comment></event>
<event id="E16">
<type class="Transcription"/>
<theme idref="A11" idref1="A12"/>
<clue>Activation also induced c-rel and p105/p50 mRNA <clueType>synthesis</clueType>, but not p65 mRNA whose expression was constitutive.</clue>
</event>
<event id="E17">
<type class="Transcription"/>
<theme idref="A13"/>
<clue>Activation also induced c-rel and p105/p50 mRNA <clueType>synthesis</clueType>, but not p65 mRNA whose expression was constitutive.</clue>
</event>
<event id="E18">
<type class="Transcription"/>
<theme idref="T23"/>
<clue>Activation also induced c-rel and p105/p50 mRNA <clueType>synthesis</clueType>, but not p65 mRNA whose expression was constitutive.</clue>
</event>
<event id="E119">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E3"/>
<clue><corefCause>Activation</corefCause> also <clueType>induced</clueType> c-rel and p105/p50 mRNA synthesis, but not p65 mRNA whose expression was constitutive.</clue>
</event>
<event id="E120">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="E3"/>
<clue><corefCause>Activation</corefCause> also <clueType>induced</clueType> c-rel and p105/p50 mRNA synthesis, but not p65 mRNA whose expression was constitutive.</clue>
</event>
<event id="E121">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="E3"/>
<clue><corefCause>Activation</corefCause> also <clueType>induced</clueType> c-rel and p105/p50 mRNA synthesis, but not p65 mRNA whose expression was constitutive.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="E3"/>
<clue><corefCause>Activation</corefCause> also <clueType>induced</clueType> c-rel and p105/p50 mRNA synthesis, but <cluePolarity>not</cluePolarity> p65 mRNA whose expression was constitutive.</clue>
</event>
<sentence id="S8">Interestingly, all those early and late events, but not the immediate ones, were inhibited by a neutralizing <term id="T25" lex="anti-tumor_necrosis_factor_alpha_(TNF-alpha)_monoclonal_antibody" sem="Protein_molecule"><term id="A16" sem="Protein_molecule">anti</term>-<term id="T26" lex="tumor_necrosis_factor_alpha" sem="Protein_molecule">tumor necrosis factor alpha</term> (<term id="A14" sem="Protein_molecule">TNF-alpha</term>) <term id="A15" sem="Protein_molecule">monoclonal antibody</term></term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E20">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="A16" idref1="A14" idref2="A15"/>
<clue>Interestingly, all those early and late events, but <cluePolarity>not</cluePolarity> <corefTheme>the immediate ones</corefTheme>, were <clueType>inhibited</clueType> <linkCause>by</linkCause> a neutralizing anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody.</clue>
</event>
<event id="E21">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="A16" idref1="A14" idref2="A15"/>
<clue>Interestingly, all <corefTheme>those early and late events</corefTheme>, but not the immediate ones, were <clueType>inhibited</clueType> <linkCause>by</linkCause> a neutralizing anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="A16" idref1="A14" idref2="A15"/>
<clue>Interestingly, all <corefTheme idref1="E13">those early</corefTheme> and late <corefTheme idref1="E13">events</corefTheme>, but not the immediate ones, were <clueType>inhibited</clueType> <linkCause>by</linkCause> a neutralizing anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody.</clue>
</event>
<event id="E23">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="A16" idref1="A14" idref2="A15"/>
<clue>Interestingly, all <corefTheme idref1="E14">those early</corefTheme> and late <corefTheme idref1="E14">events</corefTheme>, but not the immediate ones, were <clueType>inhibited</clueType> <linkCause>by</linkCause> a neutralizing anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody.</clue>
</event>
<sentence id="S9">Similarly, <term id="A17" sem="Organic_compound_other">cycloheximide</term> prevented the <term id="T27" lex="p65" sem="Protein_molecule">p65</term> and <term id="T28" lex="c-rel" sem="Protein_molecule">c-rel</term> <term id="T29" lex="translocation" sem="Other">translocation</term> and consequent formation of active binding heterodimers, at early and late times.</sentence>
<event id="E24">
<type class="Localization"/>
<theme idref="T27"/>
<clue>Similarly, cycloheximide prevented the p65 and c-rel <clueType>translocation</clueType> and consequent formation of active binding heterodimers, <clueTime>at early and late times</clueTime>.</clue>
</event>
<event id="E25">
<type class="Localization"/>
<theme idref="T28"/>
<clue>Similarly, cycloheximide prevented the p65 and c-rel <clueType>translocation</clueType> and consequent formation of active binding heterodimers, <clueTime>at early and late times</clueTime>.</clue>
</event>
<event id="E26">
<type class="Binding"/>
<theme idref="T27"/>
<theme idref="T28"/>
<clue>Similarly, cycloheximide prevented the p65 and c-rel translocation and consequent <clueType>formation</clueType> of active binding <clueType>heterodimers</clueType>, <clueTime>at early and late times</clueTime>.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="A17"/>
<clue>Similarly, cycloheximide <clueType>prevented</clueType> the p65 and c-rel translocation and consequent formation of active binding heterodimers, at early and late times.</clue>
</event>
<event id="E28">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="A17"/>
<clue>Similarly, cycloheximide <clueType>prevented</clueType> the p65 and c-rel translocation and consequent formation of active binding heterodimers, at early and late times.</clue>
</event>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="A17"/>
<clue>Similarly, cycloheximide <clueType>prevented</clueType> the p65 and c-rel translocation and consequent formation of active binding heterodimers, at early and late times.</clue>
</event>
<sentence id="S10"><term id="T30" lex="cyclosporin_A" sem="Organic_compound_other">Cyclosporin A</term> impaired not only early and late, but also immediate events; however, addition of <term id="T31" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term> prevented all inhibition.</sentence>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T30"/>
<clue>Cyclosporin A <clueType>impaired</clueType> not only early and late, but also <corefTheme>immediate events</corefTheme>; however, addition of TNF-alpha prevented all inhibition.</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="T30"/>
<clue>Cyclosporin A <clueType>impaired</clueType> not only <corefTheme idref1="E12">early and late</corefTheme>, but also immediate <corefTheme idref1="E12">events</corefTheme>; however, addition of TNF-alpha prevented all inhibition.</clue>
</event>
<event id="E32">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="T30"/>
<clue>Cyclosporin A <clueType>impaired</clueType> not only <corefTheme idref1="E13">early</corefTheme> and late, but also immediate <corefTheme idref1="E13">events</corefTheme>; however, addition of TNF-alpha prevented all inhibition.</clue>
</event>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T30"/>
<clue>Cyclosporin A <clueType>impaired</clueType> not only <corefTheme idref1="E14">early</corefTheme> and late, but also immediate <corefTheme idref1="E14">events</corefTheme>; however, addition of TNF-alpha prevented all inhibition.</clue>
</event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="T31"/>
<clue>Cyclosporin A impaired not only early and late, but also immediate events; however, addition of TNF-alpha <clueType>prevented</clueType> <corefTheme>all inhibition</corefTheme>.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T31"/>
<clue>Cyclosporin A impaired not only early and late, but also immediate events; however, addition of TNF-alpha <clueType>prevented</clueType> <corefTheme>all inhibition</corefTheme>.</clue>
</event>
<event id="E36">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T31"/>
<clue>Cyclosporin A impaired not only early and late, but also immediate events; however, addition of TNF-alpha <clueType>prevented</clueType> <corefTheme>all inhibition</corefTheme>.</clue>
</event>
<event id="E37">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T31"/>
<clue>Cyclosporin A impaired not only early and late, but also immediate events; however, addition of TNF-alpha <clueType>prevented</clueType> <corefTheme>all inhibition</corefTheme>.</clue>
</event>
<sentence id="S11">These results indicate that the regulation of <term id="T32" lex="NF-kappa_B_activation" sem="Other"><term id="T33" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term> during <term id="T34" lex="T_cell_activation" sem="Other"><term id="A18" sem="Cell_natural">T cell</term> activation</term> by <term id="A19" sem="Other"><term id="T35" lex="TcR/CD3" sem="Protein_complex">TcR/CD3</term> signals</term> is biphasic: <term id="T36" lex="TcR/CD3" sem="Protein_complex">TcR/CD3</term> triggers its immediate translocation, which is transient if no <term id="T37" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term> is present.</sentence>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<cause idref="E39"/>
<clue>These results indicate that the regulation of NF-kappa B <clueType>activation</clueType> during T cell activation by TcR/CD3 signals is biphasic: TcR/CD3 triggers its immediate translocation, which is transient if no TNF-alpha is present.</clue>
</event>
<event KT="Other" id="E39">
<type class="Physiological_process"/>
<theme idref="A18"/>
<cause idref="A19"/>
<clue>These results indicate that the regulation of NF-kappa B activation during T cell <clueType>activation</clueType> <linkCause>by</linkCause> TcR/CD3 signals is biphasic: TcR/CD3 triggers its immediate translocation, which is transient if no TNF-alpha is present.</clue>
</event>
<event KT="Other" id="E142">
<type class="Localization"/>
<theme idref="T33"/>
<clue>These results indicate that the regulation of NF-kappa B activation during T cell activation by TcR/CD3 signals is biphasic: TcR/CD3 triggers <corefTheme>its</corefTheme> immediate <clueType>translocation</clueType>, which is transient if no TNF-alpha is present.</clue>
</event>
<event KT="Analysis" id="E40">
<type class="Positive_regulation"/>
<theme idref="E142"/>
<cause idref="T36"/>
<clue>These results <clueKT>indicate</clueKT> that the regulation of NF-kappa B activation during T cell activation by TcR/CD3 signals is biphasic: TcR/CD3 <clueType>triggers</clueType> its immediate translocation, which is transient if no TNF-alpha is present.</clue>
</event>
<event KT="Analysis" id="E41">
<type class="Regulation"/>
<theme idref="E38"/>
<cause idref="E40"/>
<clue>These results <clueKT>indicate</clueKT> that the <clueType>regulation</clueType> <linkTheme>of</linkTheme> NF-kappa B activation during T cell activation by TcR/CD3 signals is biphasic: TcR/CD3 triggers its immediate translocation, which is transient if no TNF-alpha is present.</clue>
</event>
<sentence id="S12"><term id="T38" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>, therefore, emerges as the main factor responsible for a second phase of <term id="T39" lex="NF-kappa_B_regulation" sem="Other"><term id="T40" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> regulation</term>, controlling both translocation of <term id="T41" lex="p65" sem="Protein_molecule">p65</term> and <term id="T42" lex="c-rel" sem="Protein_molecule">c-rel</term>, and new <term id="T43" lex="mRNA" sem="RNA_family_or_group">mRNA</term> synthesis for <term id="T44" lex="c-rel" sem="Protein_molecule">c-rel</term> and <term id="T45" lex="p105/p50" sem="Protein_complex"><term id="A20" sem="Protein_molecule">p105</term>/<term id="A21" sem="Protein_molecule">p50</term></term>.</sentence>
<event KT="Other" id="E42">
<type class="Localization"/>
<theme idref="T41"/>
<clue>TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both <clueType>translocation</clueType> <linkTheme>of</linkTheme> p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
<event KT="Other" id="E43">
<type class="Localization"/>
<theme idref="T42"/>
<clue>TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both <clueType>translocation</clueType> <linkTheme>of</linkTheme> p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
<event KT="Other" id="E44">
<type class="Transcription"/>
<theme idref="T44"/>
<clue>TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both translocation of p65 and c-rel, and new <clueType>mRNA synthesis</clueType> <linkTheme>for</linkTheme> c-rel and p105/p50.</clue>
</event>
<event KT="Other" id="E45">
<type class="Transcription"/>
<theme idref="A20"/>
<clue>TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both translocation of p65 and c-rel, and new <clueType>mRNA synthesis</clueType> <linkTheme>for</linkTheme> c-rel and p105/p50.</clue>
</event>
<event KT="Other" id="E46">
<type class="Transcription"/>
<theme idref="A21"/>
<clue>TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both translocation of p65 and c-rel, and new <clueType>mRNA synthesis</clueType> <linkTheme>for</linkTheme> c-rel and p105/p50.</clue>
</event>
<event KT="Other" id="E47">
<type class="Regulation"/>
<theme idref="T40"/>
<clue>TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B <clueType>regulation</clueType>, controlling both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
<event KT="Analysis" id="E48">
<type class="Correlation"/>
<theme idref="E47"/>
<theme idref="T38"/>
<clue>TNF-alpha, <clueKT>therefore</clueKT>, emerges as <corefTheme>the main factor</corefTheme> <clueType>responsible</clueType> <linkTheme>for</linkTheme> a second phase of NF-kappa B regulation, controlling both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
<event KT="Analysis" id="E49">
<type class="Regulation"/>
<theme idref="E42"/>
<cause idref="T38"/>
<clue>TNF-alpha, <clueKT>therefore</clueKT>, emerges as the main factor responsible for a second phase of NF-kappa B regulation, <clueType>controlling</clueType> both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
<event KT="Analysis" id="E50">
<type class="Regulation"/>
<theme idref="E43"/>
<cause idref="T38"/>
<clue>TNF-alpha, <clueKT>therefore</clueKT>, emerges as the main factor responsible for a second phase of NF-kappa B regulation, <clueType>controlling</clueType> both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
<event KT="Analysis" id="E51">
<type class="Regulation"/>
<theme idref="E44"/>
<cause idref="T38"/>
<clue>TNF-alpha, <clueKT>therefore</clueKT>, emerges as the main factor responsible for a second phase of NF-kappa B regulation, <clueType>controlling</clueType> both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
<event KT="Analysis" id="E52">
<type class="Regulation"/>
<theme idref="E45"/>
<cause idref="T38"/>
<clue>TNF-alpha, <clueKT>therefore</clueKT>, emerges as the main factor responsible for a second phase of NF-kappa B regulation, <clueType>controlling</clueType> both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
<event KT="Analysis" id="E53">
<type class="Regulation"/>
<theme idref="E46"/>
<cause idref="T38"/>
<clue>TNF-alpha, <clueKT>therefore</clueKT>, emerges as the main factor responsible for a second phase of NF-kappa B regulation, <clueType>controlling</clueType> both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
